[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355869-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355869-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","thermal-ablation-plus-hpv-specific-igy-vaginal-gel-versus-watchful-waiting-in-women-with-histologically-confirmed-cin1-and-persistent-hpv-a-prospective-observational-cohort-study","Thermal ablation plus HPV-specific IgY vaginal gel versus watchful waiting in women with histologically confirmed CIN1 and persistent HPV - a prospective observational cohort study","","Persistent HPV infection drives cervical intraepithelial neoplasia (CIN); while CIN1 often regresses with observation, the benefit of active treatment remains uncertain. This single-centre prospective observational cohort (July 2022–July 2024) enrolled 237 women with histology-confirmed CIN1 and persistent HPV (≥1 year). Participants chose thermal ablation plus a 3-month HPV-specific IgY vaginal gel or watchful waiting. At 6 and 12 months, regression and HPV clearance were consistently higher with the combined intervention; progression to CIN2+ remained uncommon and not significantly different.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/thermal-ablation-plus-hpv-specific-igy-vaginal-gel-versus-watchful-waiting-in-women-with-histologically-confirmed-cin1-and-persistent-hpv-a-prospective-observational-cohort-study/355869/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/thermal-ablation-plus-hpv-specific-igy-vaginal-gel-versus-watchful-waiting-in-women-with-histologically-confirmed-cin1-and-persistent-hpv-a-prospective-observational-cohort-study/355869.png","ImageObject",300,407,{"name":42,"@type":43},"Mimi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study aim regarding CIN1 treatment?","Question",{"text":63,"@type":64},"To evaluate whether combining cervical thermal ablation with an HPV-specific IgY vaginal gel improves outcomes in women with histologically confirmed CIN1 and persistent HPV.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were participants assigned to treatment or control groups?",{"text":68,"@type":64},"After counselling, women chose either thermal ablation plus 3 months of HPV-specific IgY vaginal gel (treatment group) or watchful waiting (control group), with follow-up at 6 and 12 months.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main outcomes at 6 and 12 months?",{"text":72,"@type":64},"The treatment group showed greater CIN1 regression and higher HPV clearance at both 6 and 12 months, while progression to CIN2+ was uncommon and not significantly different.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355869,1790179709,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":118,"preview_page_count":33,"preview_urls":145},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Chen et al. BMC Women's Health (2026) 26:299 BMC Women's Health  \n[https://doi.org/10.1186/s12905-026-04366-6](https://doi.org/10.1186/s12905-026-04366-6)  \nRESEARCH Open Access  \nThermal ablation plus HPV-specific IgY vaginal gel versus watchful waiting in women with histologically confirmed CIN1 and persistent HPV: a prospective observational cohort study  \nMing Chen1*, Xuanhui Wang1, Salamaiti Abudurehemu1, Li Li 1 and Chunxiao Chen1  \nAbstract  \nIntroduction Persistent human papillomavirus (HPV) infection drives cervical intraepithelial neoplasia (CIN), andover time, a minority of infections progress to cancer. CIN1 typically regresses spontaneously and is usually managed with observation and repeated testing. The role of active treatment for CIN1 remains uncertain. Minimally invasive strategies might enhance lesion regression and HPV clearance. The aim of this study was to evaluate the combined use of cervical thermal ablation and HPV-specific IgY vaginal gel in the treatment of cervical CIN1 .  \nMethods In this single-centre prospective observational study (July 2022–July 2024), 237 women with persistent HPV (≥1 year) and histology-confirmed CIN1 chose either treatment (thermal ablation plus a 3-month course of the HPV-specific IgY vaginal gel Lekeduokang; treatment group, TG) or watchful waiting (control group, CG) after counselling (TG n=106; CG n=131) . Ablation was performed under colposcopy; follow-up at 6 and 12 months was used to assess lesion regression (composite cytology/histology), HPV clearance, progression to CIN2+, and safety. Results At 6 months, regression was greater in the TG than in the CG (53 . 8%/[57/106] vs. 21.4%/[28/131], P \u003C0 . 001), with higher HPV clearance (58 . 5%/[62/106] vs. 18. 3%/[24/131], P \u003C0 . 001) . Progression to CIN2+ was uncommon and not significantly different (1 . 9%/[2/106] vs. 3. 8%/[5/131], P =0 .47) . At 12 months, regression remained greater in the TG (65 . 1%/[69/106]) than in the CG (35 . 9%/[47/131], P \u003C0 . 001), and HPV clearance was greater in the TG (67 . 9%/[72/106]) than in the CG (35 . 1%/[46/131], p\u003C0 . 001) . The number of cases with progression was lower in the TG but the difference was not statistically significant (4 . 7%/[5/106] vs. 8.4%/[11/131], P =0 . 267) . Multivariate analysis revealed that treatment (ablation plus vaginal gel) was significantly related to disease regression at the 12-month follow-up (P=0 . 003) .  \nConclusion Thermal ablation plus an HPV-specific IgY vaginal gel was associated with higher 12-month regression and HPV clearance than watchful waiting in women with persistent HPV and CIN1, while progression to CIN2+ did  \n*Correspondence: Ming Chen [drchenming@163.com](drchenming@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nnot significantly differ. Given that CIN1 is generally ","cbCaiaz89Lg69tEM","https://ap.wps.com/l/cbCaiaz89Lg69tEM","pdf",1121157,"English","# Introduction\n# Methods\n## Study design and participants\n## Procedures and outcomes\n# Results\n# Conclusion\n# Key Highlights\n# Keywords","[{\"question\":\"What was the study aim regarding CIN1 treatment?\",\"answer\":\"To evaluate whether combining cervical thermal ablation with an HPV-specific IgY vaginal gel improves outcomes in women with histologically confirmed CIN1 and persistent HPV.\"},{\"question\":\"How were participants assigned to treatment or control groups?\",\"answer\":\"After counselling, women chose either thermal ablation plus 3 months of HPV-specific IgY vaginal gel (treatment group) or watchful waiting (control group), with follow-up at 6 and 12 months.\"},{\"question\":\"What were the main outcomes at 6 and 12 months?\",\"answer\":\"The treatment group showed greater CIN1 regression and higher HPV clearance at both 6 and 12 months, while progression to CIN2+ was uncommon and not significantly different.\"}]","Thermal ablation plus HPV-specific IgY vaginal gel versus watchful waiting in women with histologically confirmed CIN1 and persistent HPV - a prospective observational cohort study | PDF",1790121416,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05d01b7f28036db2b67d19646e291de6.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc3494d3bdbdee279f8348ae0bcfc286.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf76516ba1320977b175caaaa99c6102.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bab6cb42839f5265f3edc74b7fe4643.webp",980,1306]